About Us
New Paradigm Biosciences (NPB), a Boston based spin-out company from MIT and UNC-Chapel Hill, is focused on the development of novel cancer immune-therapeutics using its proprietary platform. NPB‘s platform is based on innovative humanized mouse models complimented by pipeline of novel antibodies directed at unique immune-oncology targets. We are currently expanding our operations and seeking talented scientists to join a fast-paced early stage company culture focused on the design of cutting edge treatments for cancer that have a positive impact on patients.
Open Positions
There are no open positions at this time.